Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

L-threo-3,4-dihydroxyphenylserine

EU orphan designation number: EU/3/07/465   
Active ingredient: L-threo-3,4-dihydroxyphenylserine
Indication: Treatment of orthostatic hypotension in patients with pure autonomic failure
Sponsor: H. Lundbeck A/S
Ottiliavej 9, 2500 Valby, Danmark

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
06/08/2007 Orphan designation EMEA/OD/026/07 (2007)3819 of 02/08/2007
11/12/2007 Change of name and/or address of sponsor
01/04/2009 Transfer of orphan designation EMEA/OD/026/07/T/01 (2009)2487 of 27/03/2009
09/11/2010 Change of name and/or address of sponsor EMA/581017/2010
11/03/2011 Transfer of orphan designation EMEA/OD/026/07/T/02 (2011)1683 of 09/03/2011
08/12/2015 Transfer of orphan designation EMA/OD/026/07/T/03 (2015)8953 of 04/12/2015